INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
University of Saskatchewan
Saskatoon, CanadáPublicaciones en colaboración con investigadores/as de University of Saskatchewan (4)
2024
-
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
The Lancet, Vol. 403, Núm. 10444, pp. 2597-2605
2021
-
Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic
Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552
-
Global impact of COVID-19 on stroke care
International Journal of Stroke, Vol. 16, Núm. 5, pp. 573-584